APAC computed tomography market set to grow at 3% CAGR through 2033
The key drivers of the market growth include technological advancements and a rising geriatric population, among others.
US consumers expect higher inflation and better economy, New York Fed says
(Reuters) -U.S. consumers were bracing last month for higher levels of inflation in coming years even as they marked up expectations that their personal financial situations would improve markedly, the New York Federal Reserve reported on Monday. Respondents to the regional Fed bank's survey of consumer expectations in November see inflation a year from now at 3%, versus the 2.9% expected in October, while inflation in three years is seen at 2.6%, compared to 2.5% in the previous month. The New York Fed noted educational levels affected the view on future inflation, saying "the overall increase in one- and three-year-ahead inflation expectations masks a decline among those without a college degree and an increase among those with a college degree."
Crypto Companies, Including DEXs, Look to Bermuda in Regulations Race
Bermuda is emerging as a hub for crypto and DeFi innovation, offering a sophisticated regulatory framework that has attracted companies like GRVT, the first regulated decentralized exchange, and Kraken, which launched its global derivatives venue there. This highlights how smaller, agile nations can bridge cutting-edge financial technologies with robust compliance, setting a precedent for fostering trust and legitimacy in the digital asset space.
Top Stock Movers Now: Nvidia, Hershey, Supermicro, and More
U.S. equities were down at midday, pulled lower by falling tech stocks.
Why Is Cogent Biosciences Stock Trading Higher On Monday?
On Sunday, Cogent Biosciences, Inc. (NASDAQ:COGT) revealed updated clinical results from the Open Label Extension (OLE) portion of the SUMMIT trial of bezuclastinib in patients with non-advanced systemic mastocytosis. Non-advanced systemic mastocytosis is a rare disease that involves mast cell buildup in tissues and organs. Updated clinical data presented at the American Society of Hematology Annual Meeting & Exposition show: 56% mean improvement in Total Symptom Score (TSS) at 24 weeks. 76% of
Nvidia stock falls almost 3% as it faces an antitrust probe in China
Nvidia’s (NVDA) shares fell by almost 3% during mid-day trading on Monday after the Chinese government announced an investigation into the chipmaker. Fellow chipmakers Advanced Micro Devices (AMD) and Marvell (MRVL) also saw their shares fall by 4.4% and 5.2%, respectively.
Omnicom to Purchase Interpublic Group in All-Stock Deal
Omnicom Group (OMC) agreed to acquire Interpublic Group of Cos. (IPG) in an all-stock deal to create
Argentine Oil Output Is Poised to Oust Colombia From South America’s Top Three
(Bloomberg) -- A shale-drilling frenzy in Argentina has put the country on the verge of leapfrogging regional rival Colombia as a top-three crude producer in South America.Most Read from BloombergBrace for a Nationwide Shuffle of Corporate HeadquartersA Chicago Skyscraper Cements the Legacy of a Visionary Postmodern ArchitectCloud Computing Tax Threatens Chicago’s Silicon Valley AmbitionsNYC’s Run-Down Bus Terminal Gets Approval for $10 Billion RevampKansas City Looks Back on its Long, Costly Ri
Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock
Jefferies has upgraded Kodiak Sciences Inc. (NASDAQ:KOD), a biopharmaceutical company focused on retinal (eye) diseases. Kodiak’s lead investigational medicine, tarcocimab, is an anti-VEGF antibody biopolymer conjugate under development for high-prevalence retinal vascular diseases. Tarcocimab is currently being studied in two Phase 3 trials, GLOW2 in diabetic retinopathy and DAYBREAK in patients with wet age-related macular degeneration (wet AMD). Both studies are actively enrolling patients. J
TikTok asks federal appeals court to bar enforcement of potential ban until Supreme Court review
TikTok asked a federal appeals court on Monday to bar the Biden administration from enforcing a law that could lead to a ban on the popular platform until the Supreme Court reviews its challenge to the statute. The legal filing was made after a panel of three judges on the same court sided with the government last week and ruled that the law, which requires TikTok's China-based parent company ByteDance to divest its stakes in the social media company or face a ban, was constitutional. If the law is not overturned, both TikTok and its parent ByteDance, which is also a plaintiff in the case, have claimed that the popular app will shut down by Jan. 19, 2025.